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MBoC | ARTICLE

A SUMO-targeted ubiquitin ligase is involved in
the degradation of the nuclear pool of the SUMO
E3 ligase Siz1
Jason W. Westerbeck*,†, Nagesh Pasupala*, Mark Guillotte, Eva Szymanski, Brooke C. Matson,
Cecilia Esteban, and Oliver Kerscher
Biology Department, The College of William & Mary, Williamsburg, VA 23187

ABSTRACT The Slx5/Slx8 heterodimer constitutes a SUMO-targeted ubiquitin ligase (STUbL)
with an important role in SUMO-targeted degradation and SUMO-dependent signaling. This
STUbL relies on SUMO-interacting motifs in Slx5 to aid in substrate targeting and carboxyterminal RING domains in both Slx5 and Slx8 for substrate ubiquitylation. In budding yeast
cells, Slx5 resides in the nucleus, forms distinct foci, and can associate with double-stranded
DNA breaks. However, it remains unclear how STUbLs interact with other proteins and their
substrates. To examine the targeting and functions of the Slx5/Slx8 STUbL, we constructed
and analyzed truncations of the Slx5 protein. Our structure–function analysis reveals a domain of Slx5 involved in nuclear localization and in the interaction with Slx5, SUMO, Slx8, and
a novel interactor, the SUMO E3 ligase Siz1. We further analyzed the functional interaction of
Slx5 and Siz1 in vitro and in vivo. We found that a recombinant Siz1 fragment is an in vitro
ubiquitylation target of the Slx5/Slx8 STUbL. Furthermore, slx5∆ cells accumulate phosphorylated and sumoylated adducts of Siz1 in vivo. Specifically, we show that Siz1 can be ubiquitylated in vivo and is degraded in an Slx5-dependent manner when its nuclear egress is prevented in mitosis. In conclusion, our data provide a first look into the STUbL-mediated
regulation of a SUMO E3 ligase.
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INTRODUCTION
Eukaryotic cells use the addition and removal of posttranslational
modifiers (PTMs) to control the cell division cycle. Ubiquitin and
SUMO are two small proteinaceous PTMs that modulate protein
fate and function. Ubiquitin is best known for its role in the targeted
degradation of important cell-cycle regulators, but it also holds
many nonproteolytic functions (reviewed by Ulrich and Walden,
2010; Okita and Nakayama, 2012; Yao and Ndoja, 2012). In contrast,
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SUMO modification does not necessarily lead to degradation of the
proteins to which it is attached. Instead, sumoylation modulates the
localization, interaction, and activity of target proteins, including
those involved in efficient cell cycle progression, DNA replication
and repair, transcriptional regulation, and the formation of nuclear
bodies, to name just a few (Wang and Dasso, 2009).
All eukaryotic cells carry several copies of the gene encoding
ubiquitin, a conserved 76–amino acid protein. Ubiquitin shares only
limited sequence identity with other ubiquitin-like proteins (Ubls)—
for example, SUMO (18%)—but the overall “ubiquitin fold” is structurally conserved. Mammalian cells encode three different SUMO
isoforms—SUMO1, 2, and 3—whereas budding yeast cells express
only one—Smt3—hereafter referred to as yeast SUMO. After translation, both ubiquitin and SUMO precursors are made conjugation
competent by processing through ubiquitin- and SUMO-specific
proteases, respectively. This processing exposes a carboxy-terminal
diglycine motif that is subsequently linked to a lysine side chain of a
target protein. The ATP-dependent process of substrate selection
and linkage is mechanistically conserved between Ubls. Generally,
ubiquitylation and sumoylation of proteins depend on the stepwise

Supplemental Material can be found at:
http://www.molbiolcell.org/content/suppl/2013/11/04/mbc.E13-05-0291v1.DC1

1

activity of a dedicated cascade of Ubl-specific E1 (activating), E2
(conjugating), and E3 (ligating) enzymes (reviewed by Kerscher
et al., 2006). To ensure that the correct protein is modified with
ubiquitin, ubiquitin E3 ligases recognize individual substrate proteins (reviewed in Deshaies and Joazeiro, 2009). For the majority of
sumoylation events, a consensus motif ψKXE/D (ψ being a large
hydrophobic amino acid and X any residue) in the target protein
appears sufficient for sumoylation via the E2 conjugating enzyme
Ubc9 (Sampson et al., 2001). However, in the absence of sumoylation motifs or to enhance sumoylation on specific proteins, SUMO
E3s are required. These include Siz1, Siz2, Mms21, and Zip3 in yeast
(Johnson and Gupta, 2001; Zhao and Blobel, 2005; Cheng et al.,
2006; Takahashi et al., 2006).
Siz1 and Siz2 account for the majority of E3-mediated sumoylation in yeast. These E3 ligases have some overlapping substrates,
whereas others are unique (Reindle et al., 2006). For example, the
bud neck–localized septin proteins Cdc3, Cdc11, and Shs1 depend
solely on Siz1 for their sumoylation (Johnson and Gupta, 2001;
Takahashi et al., 2001a,b). Sumoylation of these septins requires that
Siz1 be exported from the nucleus in mitosis, via the karyopherin
Msn5, to associate with septins at the bud neck of dividing cells.
Msn5 is known to transport phosphorylated cargoes, and the phosphorylation of Siz1, via an unknown kinase, may facilitate its export
from the nucleus (Takahashi and Kikuchi, 2005; Takahashi et al.,
2008; Makhnevych et al., 2007). In msn5∆ cells Siz1 is not exported
from the nucleus and septins remain unsumoylated (Makhnevych
et al., 2007).
Both ubiquitin and SUMO can form chains on the targets they
modify. Ubiquitin has seven lysines, and at least five of these (K6,
K11, K29, K48, K63) can serve as conjugation sites for additional
ubiquitin molecules (Wickliffe et al., 2009). In contrast, all SUMO
variants, except SUMO1, form chains through lysines in their amino
terminus. Yeast SUMO has three lysines (K11, K15, and K19), all centered on sumoylation consensus sites, that are required for SUMOchain formation (Bylebyl et al., 2003; Ulrich, 2008). SUMO chains
accumulate due to heat shock, osmotic stress, and replicative stress
(Vertegaal, 2010). As detailed later, the exact role of SUMO chains in
the cellular stress response is not entirely clear. However, SUMO
chains can also become ubiquitylated via SUMO-targeted ubiquitin
ligases (STUbLs), and these branched Ubl structures may play an
important role in protein degradation and signaling (Guzzo et al.,
2012; Guzzo and Matunis, 2013; Nie et al., 2012).
STUbLs, first functionally identified in yeasts, have given credence to a proteolytic role of SUMO. STUbLs are ubiquitin E3 ligases that can specifically target and bind SUMO chains or proteins
modified with SUMO chains and facilitate their ubiquitylation, although recent evidence suggests that STUbLs may not always require SUMO or SUMO chains to interact with their substrates (Xie
et al., 2010). Members of this unusual family of ubiquitin ligases are
exquisitely conserved and have been identified in yeasts, flies, frogs,
fish, mice, and humans (reviewed by Prudden et al., 2007; Geoffroy
and Hay, 2009; Praefcke et al., 2012). There are four STUbL proteins
(Slx5, Slx8, Ris1, Rad18) in the budding yeast Saccharomyces cerevisiae, three in fission yeast Schizosaccharomyces pombe (Rfp1, Rfp2,
and Slx8), and at least one in multicellular eukaryotes, including humans (RNF4; Wang et al., 2006; Sun et al., 2007; Uzunova et al.,
2007; Xie et al., 2007; Tatham et al., 2008; Mukhopadhyay et al.,
2010; Parker and Ulrich, 2012). Budding yeast Slx5 and Slx8 form a
complex that plays an important role in the DNA damage response,
genome maintenance, and proteasome-mediated degradation of
specific transcriptional regulators. Included in a growing list of
experimentally confirmed ubiquitylation targets of Slx5/Slx8 are the
2 | J. W. Westerbeck et al.

transcriptional regulators Mot1 and Matalpha2 (in vivo), the homologous recombination protein Rad52 (in vitro), and sumoylated Nfi1/
Siz2 (in vitro; Zhang et al., 2006; Nagai et al., 2008; Cook et al.,
2009; Wang and Prelich, 2009; Xie et al., 2010; Garza and Pillus,
2013). In contrast, Ris1 has been proposed to target cytosolic proteins, including sumoylated Pac1, a microtubule-associated protein
(Alonso et al., 2012). Rad18, a SIM-containing ubiquitin ligase that is
stimulated by sumoylation of its substrate, the sliding clamp protein
PCNA, is likely the newest member of a growing family of STUbLs
(Parker and Ulrich, 2012). Apart from specific protein substrates,
among the most important targets of STUbLs may be SUMO chains.
This is illustrated by the observation that STUbL mutants accumulate
high–molecular weight SUMO chains (Uzunova et al., 2007; Xie
et al., 2007). However, our mechanistic understanding of SUMO
chains is limited, and whether these polymers are beneficial or detrimental to cellular processes may depend on several factors, including growth conditions and genetic background (Uzunova et al.,
2007; Mullen et al., 2011; Tan et al., 2013). In general, there is also
clear evidence that the accumulation of SUMO conjugates in SUMO
protease mutants is linked to vegetative growth, cell cycle progression, and other defects (Li and Hochstrasser, 1999, 2000). Of note,
Slx5 was identified as a high-copy suppressor of a temperature-sensitive SUMO protease mutant, ulp1ts (Xie et al., 2007).
STUbLs use SIMs to interact noncovalently with SUMO, SUMO
chains, and sumoylated substrate proteins. A consensus SIM sequence consists of a hydrophobic core (V/I-X-V/I-V/I) that is often
juxtaposed with a stretch of acidic and/or phosphorylated amino
acids (Kerscher, 2007). Slx5 is the targeting subunit of the Slx5/Slx8
STUbL and contains at least four SIMs, but only two are essential for
the interaction with SUMO and the formation of nuclear Slx5 foci
(Xie et al., 2007, 2010; Cook et al., 2009). Multiple SIMs in Slx5 are
believed to increase the affinity of Slx5/Slx8 for SUMO chains or
polysumoylated proteins. SIMs are not limited to STUbLs, and proteins that otherwise lack affinity for each other may use SUMO to
interact through SIMs. This can be useful for subcellular targeting
and the formation of large protein complexes—for example, during
the biogenesis of PML bodies (Lin et al., 2006; Shen et al., 2006). In
addition, some proteins contain both SIMs and ubiquitin-interacting
motifs, and it is believed that these proteins may be able to interact
with hybrid SUMO–ubiquitin chains formed by STUbLs. For example, hybrid SUMO–ubiquitin chains formed by Slx5/Slx8 and RNF4
are recognized by yeast Ufd1 (the substrate-recruiting cofactor of
the Cdc48p-Npl4p-Ufd1p complex) and mammalian Rap80 (a ubiquitin-interacting motif containing protein with a role in the DNA
damage response), respectively. Thus hybrid SUMO–ubiquitin
chains serve as “coded keys” representing a SUMO-dependent signal that helps orchestrate DNA repair functions (Guzzo et al., 2012;
Guzzo and Matunis, 2013; Nie et al., 2012).
Here we describe the results of a structure–function analysis of
Slx5. In the course of this study we determined that Slx5 interacts
with the mitotically regulated SUMO E3 ligase Siz1 in vitro and in
vivo. Budding yeast cells exhibit a closed mitosis, and Siz1 is unusual
in that it is exported from the intact nucleus at the onset of mitosis to
sumoylate septins at the bud neck of dividing cells. Several observations now suggest that Siz1 is a cell cycle–dependent target of the
Slx5/Slx8 STUbL. First, Slx5/Slx8 ubiquitylates a Siz1 construct in
vitro. Second, we find that slx5∆ cells contain increased steady-state
levels of phosphorylated and sumoylated Siz1 in vivo. Finally, Siz1
protein that remains in the nucleus after the onset of mitosis is degraded in an Slx5-dependent manner. These data provide a first look
into the cell cycle–dependent regulation of SUMO ligase activity via
STUbLs.
Molecular Biology of the Cell

Considering the important role of
STUbLs in DNA repair and genome maintenance, we asked whether particular domains
of Slx5 are required for nuclear localization.
Therefore we determined the localization of
six carboxy-terminal (C1–C6) Slx5 truncations in yeast (Figure 1A). These Slx5 truncations differed by ∼100 amino acids (aa) in
length, with one exception. The Slx5 construct C6 was 50 aa in length and contained
only SIM1 of Slx5 (Figure 1A). All green fluorescent protein (GFP)–tagged Slx5 truncations and the full-length Slx5-GFP control
(Cook et al., 2009) were expressed under
control of the native Slx5 promoter from
low-copy plasmids. Representative images
of live yeast cells expressing GFP-tagged
Slx5 truncations were recorded at early log
phase (Figure 1B). Image analysis of our
Slx5-GFP constructs revealed that the absence of the Slx5 RING domain (aa 490–620)
and SIM5 (476–479) does not grossly affect
nuclear localization and formation of nuclear
foci (constructs C1 and C2; see Figure 1 legend for incidence of foci). Of interest, a truncation consisting only of the amino-terminal
half of Slx5 (C3: 1–310) was still enriched in
the nucleus. This nuclear localization was
FIGURE 1: Targeting of Slx5 depends on a nuclear-localization domain and SIMs (A) Graphic
abruptly altered in a slightly shorter Slx5depiction of six carboxy-terminal truncations (C1–C6) of Slx5. The length of each truncation
GFP truncation (C4: Slx5-GFP(1–207)). Slx5construct is indicated by the scale above, with full-length Slx5 being 620 amino acids in length.
GFP(1–207) appeared to reside both in the
Also indicated are previously identified SIMs and the RING domain (dark gray) of the full-length
cytoplasm and in the nucleus and lacked
(WT) Slx5 protein, a small Slx5 domain (207–310) implicated in nuclear localization and
distinct foci. It is unlikely that the Slx5dimerization, and a full-length Slx5 deletion construct lacking an arginine-rich region, ∆188–260.
GFP(1–207) fusion protein simply leaked
Point mutations in Sim1 and 2 are indicated as asterisks. (B) Subcellular localization of GFPtagged Slx5 truncations (C1–C6) indicated in A. Plasmids expressing GFP-tagged C1–C6
from the nucleus because this GFP-tagged
constructs and the Slx5 domain (207–310) were transformed into yeast cells to determine their
Slx5 truncation is larger (57 kDa) than
subcellular localization in comparison to full-length WT Slx5-GFP. Notice nuclear Slx5 foci present the defined molecular weight for passive
in C1 (foci 32 ± 7.3%, n = 352), C2 (foci 42.5 ± 3.72%, n = 271), and C3 (foci 23 ± 10.5%, n = 232). nuclear diffusion (Shulga et al., 2000).
Constructs C4–C6 are distributed throughout the cells, with an additional enrichment of C4 at
As expected, constructs that were even
the bud neck (yellow arrow) of dividing cells (bud neck localization 11.5 ± 1.29%, n = 374).
smaller than Slx5(1–207)-GFP—C5(1–104)
GFP-tagged Slx5(207–310) is enriched in the nucleus (red arrows), suggesting that this domain is
important for nuclear localization of Slx5. Reciprocally, an overlapping construct, Slx5(∆188–260)- and C6(1–50)—also failed to be enriched in
GFP, is redistributed between the nucleus and the cytosol. The nuclear Slx5-GFP signal averaged the nucleus.
We further investigated the functional
64.5 ± 4.9% (n = 85 nuclei, red arrows, bottom) compared with 56 ± 2.3% (n = 84 nuclei, blue
relevance of the Slx5(207–310) domain.
arrows) in the Slx5(∆188-260)-GFP mutant (Kruskal–Wallis test, 109.3; df = 1; p < 0.001). Note
that both constructs in the bottom also contain point mutations in Sim1 and Sim2 (indicated by
Fusion of Slx5(207–310) to GFP revealed
asterisks) to ensure that the localization was unbiased of association with SUMO and sumoylated that this domain, when expressed in wildproteins in the nucleus and the cytosol. Furthermore, the localization of both constructs in the
type yeast cells, is involved in nuclear
bottom was evaluated in an slx5/slx8 double mutant to prevent association with endogenous
localization. Slx5(207–310)-GFP shows a
Slx5 and Slx8. n, number of log-phase cells imaged and analyzed ± SD.
diffuse nuclear enrichment with some
residual cytosolic staining (Figure 1B,
207–310). We were unable to identify a specific NLS in this doRESULTS
main but noticed that the overlapping region from amino acid
Targeting of Slx5 depends on a nuclear-localization domain
188 to 260 was enriched in arginine residues. Therefore we genand SIMs
erated an Slx5(∆188–260)-GFP construct and found that its nuSlx5 is the targeting subunit of the heterodimeric Slx5/Slx8 STUbL
clear localization was reduced, with a concomitant redistribution
complex in budding yeast. The Slx5 protein contains at least four
to the cytosol (Figure 1B). Image analysis revealed a significant
SIMs (amino acids 24–158) and a carboxy-terminal RING domain
reduction of nuclear localization (Kruskal–Wallis test, 109.3;
(amino acids 490–620; Figure 1A; Mullen et al., 2001; Uzunova
df = 1; p < 0.001) for the Slx5(∆188–260)-GFP mutant. However,
et al., 2007; Xie et al., 2007, 2010; Cook et al., 2009). We previbecause nuclear localization of the deletion mutant is not
ously reported that SIMs in Slx5 are involved in the formation of
completely abolished, we conclude that additional determinants
nuclear foci, whereas the RING domain is required for substrate
of nuclear localization may reside in the carboxy terminus of
ubiquitylation by the Slx5/Slx8 heterodimer (Xie et al., 2007; Cook
Slx5.
et al., 2009).
Volume 25 January 1, 2014

Cross-talk of ubiquitin and SUMO ligases

| 3

A truncation of Slx5 is enriched at the bud neck
of dividing cells
Careful analysis of the carboxy-terminal truncations of Slx5 revealed
that Slx5-GFP(1–207) not only accumulated in the cytoplasm but also
was visibly enriched at the bud neck of dividing cells (11.5 ± 1.29%,
n = 374; Figure 1B). We reasoned that this localization was due to the
SIM-mediated association of Slx5(1–207)-GFP with sumoylated septins at the bud neck. Septins, including Cdc3, Cdc10, Cdc11, Cdc12,
and Shs1, form a filamentous ring structure at the bud neck between
mother and daughter cell of dividing yeast (Douglas et al., 2005; Cao
et al., 2009). SUMO modification of Cdc3, Cdc11, and Shs1 in mitosis
plays an important role in septin ring dynamics (Johnson and Blobel,
1999) but may also serve to recruit SIM-containing and SUMO-binding proteins in mitosis (Kusch et al., 2002; Elmore et al., 2011).
To test whether Slx5(1–207) colocalized with individual septins,
we chromosomally tagged CDC3 with the gene encoding the yellow fluorescent protein (YFP; YOK1325). This CDC3-YFP strain
was then transformed with a plasmid encoding Slx5(1–207) fused
to the gene encoding the cyan fluorescent protein (CFP; strain
YOK1364). Live imaging of G2/M-arrested cells revealed that both
Cdc3-YFP and Slx5(1–207)-CFP fusion proteins were expressed and
colocalized to septin rings in the majority (∼80%) of large-budded
cells (Figure 2A). In logarithmically growing cells colocalization of
Slx5(1–207)-CFP and Cdc3-YFP to one or two septin rings was observed (∼20%). However, as expected, the colocalization was limited
to large-budded cells in mitosis.
Next we tested our hypothesis that the localization of Slx5(1–
207)-GFP to the septin ring was dependent on SUMO. We examined
the ability of Slx5(1–207) with SIM1/2 mutations (25-AAA-27 and 93ATAA-96) to bind to septins. We previously showed that SIM1 and
SIM2 play a critical role in the formation of Slx5 nuclear foci and
SUMO binding (Xie et al., 2007; Cook et al. 2009). The Slx5(1-207)
SIM1/2 mutant and a control plasmid with intact SIMs were transformed into a wild-type strain, and G2/M-arrested cells were examined. The Slx5(1–207) construct was localized throughout the cell but
was also visually enriched at the bud neck of 65% of G2/M-arrested
cells (Figure 2B, top left). Of note, the enrichment of the Slx5(1–207)
SIM1/2 mutant at septins was barely visible, and only a few cells
displayed residual staining at the bud neck (Figure 2B, top right).
Next we expressed Slx5(1–207)-GFP in a strain that is unable to form
polySUMO chains (smt3-R11,15,19; Bylebyl et al., 2003). Here we
found that Slx5(1–207) septin localization was reduced to ∼27% but
not eliminated in smt3(R11,15,19) cells (Figure 2B, bottom left).
Finally, we also tested a deletion of the SUMO E3 ligase gene
SIZ1, which is required for the sumoylation of bud neck–localized
septins in mitosis (Johnson and Blobel, 1999). Consistent with the
foregoing data, Slx5(1–207)-GFP localization to septins was greatly
reduced or absent in siz1∆ cells (Figure 2B, bottom right). In summary, these data suggest that the bud neck localization of the cytosolic Slx5(1–207) truncation depends on both the cell cycle–specific
sumoylation of septins and the SIMs in Slx5. However, we cannot
exclude the possibility that Siz1 recruits this construct to the bud
neck. Even though we found no evidence that septins are physiological targets of this STUbL subunit, our observations provide a visual in vivo assay for SUMO-dependent targeting of Slx5 to a highly
sumoylated target, the septins (Elmore et al., 2011).

The STUbL subunit Slx5 has distinct and separate domains
for interaction with Slx8, Slx5, and SUMO
The results obtained in our localization studies (Figure 1B) raised the
possibility that individual domains of Slx5 may functionally interact
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FIGURE 2: A Slx5 truncation containing four SIMs but lacking the
potential nuclear localization domain (207–310) is enriched at the
septin ring of G2/M-arrested cells. (A) Cells expressing the YFPtagged septin protein Cdc3-YFP (YOK1325) were transformed with
SLX5(1-207)-CFP (compare construct C4; BOK 507) and then
arrested in G2/M before microscopic analysis in live cells.
Slx5(1-207)-CFP was present diffusely throughout the cells but was
visibly enriched at the bud neck of G2/M-arrested cells
(pseudocolored in green), where it colocalized with Cdc3-YFP at the
septin ring (pseudocolored in red). Colocalization was observed in
∼80% of cells showing expression of both constructs. (B) The bud
neck localization of SLX5(1–207) depends on SIMs and the SUMO
ligase Siz1. SLX5(1–207)-GFP (BOK505) and a mutant lacking SIM1
and 2 (1–207(∆sim1/2)) were transformed into yeast cells to
determine the requirement for bud neck localization of each
construct in G2/M-arrested cells (top left and right). Slx5(1-207)-GFP
septin enriched at the bud neck of G2/M-arrested cells was
observed in 65 ± 15% of WT cells (n = 162, white arrows). In
contrast, septin localization of Slx5(1–207(∆sim1/2)) was greatly
reduced or absent (n = 108, yellow arrows). The localization of
Slx5(1–207)-GFP was then analyzed in a strain expressing a mutant
SUMO protein that fails to form chains (bottom left, smt3(R11,15,19)
or strains deleted for the SUMO ligase Siz1, which sumoylates
septins (bottom right, siz1∆). Note that bud neck localization was
still observed in 27.4 ± 14.9% of smt3(R11,15,19) cells (n = 338) but
not in the siz1∆ mutant (yellow arrowhead). n, number of
G2/M-arrested cells imaged and analyzed.

Molecular Biology of the Cell

found that a full-length Slx5 bait can also interact with other Slx5 prey proteins, raising
the possibility that this STUbL subunit, similar to its human orthologue RNF4, may homodimerize (Liew et al., 2010).
Analysis of the Slx5 bait truncations reveals that at least one SIM (SIM1: 24VILI27)
is required for interaction with yeast SUMO
(Smt3; Figure 3: C6 with SUMO). In contrast,
the interaction of Slx5 bait with other Slx5
prey proteins was independent of SIM1, 2,
3, and 4 and dependent on a novel domain
between amino acids 207 and 310 (Figure 3:
N4 and C3 with SLX5). Of interest, Slx5(207–
310) overlapped with the domain involved
in nuclear localization of Slx5 (Figure 1B, red
arrow). One possible explanation for this
finding is that homodimerization is required
for nuclear import or nuclear retention of
Slx5. Several examples of proteins that require dimerization for nuclear import exist
(Fryrear et al., 2009; Hayes et al., 2009).
However, dimerization of Slx5 is a possibility
that requires further investigation.
The interaction of Slx5 with Slx8 was
more complex. One SLX5 truncation (C1),
retaining only two cysteine residues (Cys494 and Cys-497) of the RING domain,
showed a reproducible interaction with Slx8.
Surprisingly, none of the Slx5 amino-terminal deletions (N1–N6) scored positive in our
interaction assay with Slx8. This suggests
that the amino terminus but not the entire
FIGURE 3: Slx5 uses distinct domains to interact with Slx8, Slx5, yeast SUMO (Smt3), and Siz1.
(A) Graphic depiction of six carboxy-terminal deletions (C1–C6) and six amino-terminal deletions RING domain of Slx5 is required for interaction with Slx8. To further investigate how
(N1–N6) of Slx5. The length of each truncation construct is indicated by the scale above, with
Slx5 interacts with Slx8, we used a full-length
full-length Slx5 being 620 amino acids in length. Also indicated are previously identified SIMs
Slx5 bait construct lacking both SIM1 and
and the RING domain (dark gray) of the full-length (WT) Slx5 protein. (B) Analysis of two-hybrid
interaction of WT Slx5 and various Slx5 truncations (C & N). Duplicate spots of yeast cell colony
SIM2 (Slx5(∆sim1/2); Xie et al., 2007). Fullpatches indicate two-hybrid interactions of Slx5 with full-length Slx5, Slx8, Smt3, and Siz1
length Slx8 prey and full-length Slx5(∆sim1/2)
(bottom). Interactions of Slx5, Slx8, Smt3, and Siz1 with individual Slx5 truncations (aminobait were cotransformed into the two-hybrid
terminal, N1–N6; carboxy-terminal, C1–C6) correspond to the Slx5 truncations in A (see arrows). assay strain. As a control, both constructs
Refer to Materials and Methods for details of the two-hybrid analysis. Note that the domain
were also tested against SMT3 and SLX5
encompassing amino acids 207–310 of Slx5 is required for interaction with full-length Slx5 and
constructs. In accordance with the foregothat the interaction pattern of Slx5 with SUMO (Smt3) mirrors that with Siz1. (C) Graphic
ing data, the Slx5(∆sim1/2) mutant interdepiction of Slx5 interaction derived from our structure–function analysis in Figures 1 and 2 and
acted strongly with Slx5, failed to interact
this figure. Depicted are Slx5 amino acids 1–620 (increments indicate our constructs), with
with Smt3, and was greatly reduced in its
SIM1–5 and the RING domain, an arginine-rich domain that may be involved in nuclear
interaction with Slx8 (Supplemental Figure
localization that overlaps the Slx5 interaction domain and is marked with a gray bar.
S1). Therefore both SIMs and the RING domain of Slx5 may be important for the interaction with Slx8. In sumwith different proteins such as sumoylated substrates, other STUbL
subunits, or nuclear transport factors.
mary, our two-hybrid fine-structure mapping defines four distinct
To test this hypothesis, we initially focused on the interaction of
Slx5 domains required for interaction with Smt3 (aa 1–207), Slx5 (aa
Slx5 with two known interactors, SUMO and Slx8 (Ii et al., 2007; Xie
207–310), and Slx8 (aa 1–50 and 490–620).
et al., 2007; Mullen and Brill, 2008). Specifically, we delineated the
The STUbL subunit Slx5 forms a complex with the SUMO
interaction domains of Slx5 using a collection of six amino-terminal
ligase Siz1
(N1–N6) and six carboxy-terminal Slx5 bait truncations (C1–C6;
Figure 3A). Full-length or truncated Slx5 bait constructs (Gal4-BD
Because Slx5(1–207) localized to septin rings in a SUMO-targeting
fusions) were cotransformed with the appropriate prey constructs
assay, we decided to test its interaction with potential sumoylated
(Gal4-AD fusion of Slx8 or SUMO) into a two-hybrid reporter strain
substrate proteins at the bud neck. Despite its enrichment at the
septin ring, Slx5(1–207) failed to interact with the septins Cdc3 and
(AH109). Bait/prey interactions were scored as growth of double
transformants on growth media lacking adenine and/or histidine
Cdc11 (unpublished data). However, Slx5 interacted in a two-hybrid
(Figure 3B). Our data confirmed that full-length Slx5 interacts with
assay with a known septin-interacting protein, the SUMO E3 ligase
SUMO and Slx8 (Figure 3B, bottom). Furthermore, we unexpectedly
Siz1 (Figure 3B, bottom right). Siz1 resides in the nucleus but
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becomes enriched on the septin ring during the G2/M phase of the
cell cycle, presumably to sumoylate septins. Accordingly, in the absence of Siz1, septins, including Cdc3 and Cdc11, fail to be sumoylated (Johnson and Gupta, 2001).
We decided to investigate which domain of Slx5 was required for
the interaction with Siz1. Using our panel of 12 Slx5 two-hybrid
baits, we found that interaction with Siz1 requires at least two SIMs
(SIM1 and 2) in Slx5 (Figure 3B, construct C5). The observed interaction closely mirrors the pattern we observed for interaction between
our Slx5 bait constructs and SUMO. This suggests that the interaction of Slx5 with Siz1 may depend on SUMO and possibly sumoylation of Siz1. Indeed, when we tested the interaction of Siz1 with the
Slx5(∆sim1/2) or a Siz1-RING mutant (Siz1(C377S H379A)), we no longer
observed the interaction (Supplemental Figure S1).
To confirm our finding of the Slx5–Siz1 interaction, we tested
whether both proteins could interact in vitro and in vivo. First we
probed the ability of recombinant Slx5 and Slx8 to interact with a
purified truncation of Siz1 (Siz1(∆440)). Siz1(∆440) lacks the carboxyterminal 439 amino acids but retains its SUMO ligase activity and
can be stably expressed in bacterial and yeast cells (Takahashi and
Kikuchi, 2005). To accomplish this task, we mixed bacterial protein
extracts containing overexpressed maltose-binding protein (MBP)
fusions of Slx5 or Slx8 (Xie et al., 2007) with bacterial extracts containing overexpressed, T7-tagged Siz1(∆440). Extracts were then
passed over amylose affinity resins. We observed that Siz1(∆440)
bound to the amylose affinity resins only when Slx5-MBP or Slx8MBP was also bound (Figure 4A, lanes 1 and 2). This suggests that
recombinant Siz1(∆440) can interact with both Slx5 and Slx8 in
vitro.
Second, we constructed a yeast strain in which glutathione
S-transferase (GST)–tagged Slx5 and V5-tagged Siz1(∆440) were
both expressed from plasmids under control of the strong inducible
Gal promoter. From lysates of this strain, Slx5-GST was affinity purified on glutathione agarose, and copurifying Siz1(∆440)-V5 was detected after immunoblotting with an anti-V5 antibody (Figure 4B,
lanes 5 and 7). In contrast, Siz1(∆440) expressed in the absence of
Slx5-GST did not bind to glutathione agarose (Figure 4B, compare
lanes 3 [flowthrough] and 6 [elution]). In summary, we conclude that
the SUMO ligase Siz1 can form a complex with the STUbL-targeting
subunit Slx5 in yeast cells.

Siz1 is an in vitro and in vivo ubiquitylation substrate
of Slx5/Slx8
The evidence presented here suggests that Siz1 forms a complex
with Slx5 in living cells. Therefore we tested Siz1 as a candidate
substrate for the Slx5/Slx8 STUbL. We purified the Siz1(∆440) truncation and combined it with recombinant Slx5 and Slx8 in an in vitro
ubiquitylation reaction (see Materials and Methods). In this assay we
found Siz1(∆440) to be ubiquitylated in an ATP-, E2-, and E3 (Slx5/
Slx8)-dependent manner (Figure 5A). Addition of an amino-terminal
SUMO moiety to Siz1(∆440), forming SUMO-Siz1(∆440), did not
dramatically stimulate the ubiquitylation of this fusion protein (unpublished data). This is in accordance with the previous finding that,
at least in vitro, SUMO modification is not an absolute requirement
for the specific ubiquitylation by Slx5/Slx8 (Xie et al., 2007, 2010).
Another interesting observation is that Siz1 is robustly ubiquitylated
by Slx5/Slx8, but only with two or three ubiquitin moieties. One possibility is that more extensive ubiquitylation of Siz1 can take place in
vivo.
Consequently, we tested whether Siz1 is also ubiquitylated in
vivo. Briefly, we used a ubiquitin-shift assay to compare adducts of
yeast-expressed Siz1∆440, modified either with myc-tagged or
6 | J. W. Westerbeck et al.

FIGURE 4: The STUbL subunit Slx5 forms a complex with the SUMO
ligase Siz1. (A) Slx5 and Slx8 interact with Siz1 in vitro. Recombinant
MBP-Slx5, MBP-Slx8, and T7-tagged Siz1(∆440)-His6 (BOK 500, BOK
501, BOK 758) were produced in bacterial cultures. Then 50 OD units
of induced Slx5 and Slx8 cultures were individually combined with 50
OD units of Siz1(∆440). Siz1(∆440), 50 OD units, served as a negative
control. Whole-cell extracts from the combined or control cultures
(Input) were clarified by centrifugation and passed over a column
containing amylose resin. After extensive washing, eluates (elute)
corresponding to ∼1 OD unit of input material were analyzed with an
anti-T7 antibody (left). Simply Blue staining (Life Technologies) of a gel
with duplicate samples (1–3) reveals the bound recombinant Slx5
(∼125 kDa) and Slx8 (∼90 kDa) but not the control Siz1(∆440) protein
(∼60 kDa) on the amylose resin (right). (B) Slx5 interacts with Siz1 in
vivo. We harvested 20 OD units of cells from strains overexpressing
GST-Slx5 only (YOK 2507), GST-Slx5 and Siz1(∆440)-HA (YOK 2509), or
Siz1(∆440)-HA only (YOK 2508) and prepared protein extracts by
bead-beating. Clarified extracts were passed over individual
glutathione agarose columns, and bound proteins were eluted after
extensive washing with 10 mM reduced glutathione (lanes 4–6) or
sample buffer (lanes 7 and 8). Also shown are input material (0.3% of
total OD harvested) for strain YOK 2509 (lane 1) and flowthrough for
strains YOK 2509 and YOK 2508 (lanes 2 and 3). “Elute” loaded
corresponds to 0.45% of total OD harvested. Presence or absence of
Slx5-GST and Siz1(∆440)-HA in each sample is indicated as + or –,
respectively. All samples were separated by SDS–PAGE, and individual
proteins were detected after Western blotting using anti-GST or
anti-HA antibodies as indicated. Note that Siz1(∆440) is only eluted
when Slx5-GST is bound to the affinity resin (lanes 5 and 7), indicating
an in vivo interaction between the two proteins.
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FIGURE 5: Ubiquitylation of Siz1 by Slx5/Slx8 in vitro. In vitro STUbL
ubiquitylation reactions, detailed in Materials and Methods, were
assembled with the recombinant proteins E1 (Uba1), E2 (Ubc4), and
E3 (Slx5 and Slx8), ATP, and substrate (SUB, Siz1(∆440)). As controls,
individual components were omitted from the indicated reactions in
lanes 1–4 (–ATP, –E2, –E3, –SUB). After incubation, the substrate
protein in all reactions was analyzed by immunoblotting with an
anti-T7 antibody. Lane 5 contains the complete reaction (ALL) and
reveals STUbL-dependent ubiquitylation of Siz1 (Siz1(∆440)-(Ub)n
(lane 5). Molecular weights in kilodaltons are indicated on the left.
(B) Slx5-dependent ubiquitylation of Siz1∆440 in vivo. Siz1∆440 was
expressed in yeast cells (WT or slx5∆), and a ubiquitin-shift assay was
used to compare adducts of Siz1∆440 modified either with myctagged or untagged ubiquitin G76A (+ or –). Siz1∆440 was detected
in whole-cell TCA extracts (WCE) or after immunoprecipitation with
anti-V5 agarose (IP). Differentially shifted ubiquitylated adducts of
Siz1∆440 are indicated with white and gray arrows (top). Bottom,
Western blots of the same samples probed with an anti-myc antibody
to reveal shifted bands that correspond to myc-tagged ubiquitin.

untagged ubiquitin G76A (Ubi(G76A)). Ubi(G76A) can still be conjugated
to proteins but is resistant to deubiquitylation, making it a useful
tool for studying potential ubiquitylation targets such as Siz1∆440
(Hodgins et al., 1992). Whole-cell extracts and immunoprecipitations show differentially shifted Siz1∆440 adducts, indicating that
the protein is ubiquitylated in vivo (Figure 5B, left and middle).
These adducts resembled those seen in the in vitro assays. Using
the same technique, we also showed that ubiquitylation of Siz1 is
dramatically reduced in an slx5∆ mutant (Figure 5B, right). Therefore
we conclude that the Slx5/Slx8 STUbL can ubiquitylate Siz1∆440 in
vitro and in vivo.

Slx5 affects the steady-state level, phosphorylation,
and sumoylation of Siz1 in vivo
Our data are consistent with a role for Slx5 and STUbL-mediated
regulation of Siz1. To address the functional relevance of this interVolume 25 January 1, 2014

FIGURE 6: Slx5 affects the steady-state level and phosphorylation
status of Siz1. (A) Altered steady-state level of Siz1 in slx5∆ cells. A
heterozygous diploid SLX5/slx5∆ SIZ1/SIZ1-myc/HIS3 strain was
sporulated, and the resulting haploid progeny of two tetrads (tetrad 7
[YOK 2279-2282] and tetrad 10 [YOK 2283-2286]) were genotyped
(WT and ∆). Proteins were extracted from the indicated haploid
strains to determine the steady-state levels of the myc-tagged Siz1
protein in WT and slx5∆ progeny. An anti-myc antibody was used to
detect Siz1 on immunoblots of SDS–PAGE–separated proteins. Note
the increased steady-state levels and modifications of Siz1 in slx5∆
strains (tetrad 7-4 and tetrad 10-3) in comparison to Siz1 levels in WT
strains (tetrad 7-1 and tetrad 10-4). Equal protein loading of all
extracts was determined using an anti-Pgk1 antibody. (B) Siz1 is
differentially phosphorylated under various growth conditions in WT
(YOK 2286) vs. slx5∆ (YOK 2264) cells. Log, untreated, logarithmically
growing cells; HU, hydroxyurea treatment to arrest in S phase; NZ,
nocodazole treatment to arrest in G2/M. Endogenous, myc-tagged
Siz1 protein in WT and slx5∆ cells was detected after immunoblotting
of SDS–PAGE–separated proteins using an anti-myc antibody. Single
and double asterisks denote differentially phosphorylated forms of
Siz1. Equal protein loading of all extracts was determined using an
anti-Pgk1 antibody.

action, we determined the steady-state level of chromosomally expressed Siz1 protein in wild-type (WT) and slx5∆ strains. Briefly, an
slx5∆ strain expressing myc-tagged Siz1 was backcrossed to an
isogenic WT strain. As expected, in meiotic progeny that expressed
myc-tagged Siz1, the protein was detected as a distinctive band
running just below the 150-kDa marker after Western blotting with
a myc-specific antibody (Figure 6A, tetrad 7, spores 1 and 4, and
tetrad 10, spores 3 and 4). Surprisingly, the steady-state levels of the
Siz1 protein in slx5∆ strains (Figure 6A, tetrad 7, spore 4, and tetrad
10, spore 3) were markedly enhanced in comparison to the WT
(tetrad 7, spore 1, and tetrad 10, spore 4). In addition, increased
levels of high–molecular weight adducts of Siz1-myc, consistent
with its sumoylation, were visible in the slx5∆ strain. Siz1 was previously shown to be autosumoylated in vivo, and these data are consistent with our analysis of in vivo Siz1 sumoylation in a SUMO shift
assay and after metal affinity chromatography (Supplemental Figure
S2; Takahashi and Kikuchi, 2005).
It is also well established that Siz1 is phosphorylated by an unknown kinase, and, as described earlier, this modification may be
linked to its nuclear export before septin sumoylation (Johnson and
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Gupta, 2001; Makhnevych et al., 2007). Therefore we also investigated the phosphorylation status of Siz1 in slx5∆ and WT cells. First
we observed the phosphorylation of Siz1 in both slx5∆ cells and WT
cells when cells were logarithmically grown, arrested in S phase with
hydroxyurea (HU), or arrested in G2/M with nocodazole (Figure 6B).
We confirmed the phosphorylation of Siz1 on Phos-tag gels (Wako
Pure Chemicals Industries, Osaka, Japan), which further separated
phosphorylated and unphosphorylated forms of the protein. In our
analysis we found that the levels of both unphosphorylated and two
discernible forms of phosphorylated Siz1 were markedly enhanced
in slx5∆ cells. The effect of slx5∆ was less pronounced after HU and
nocodazole treatment, with almost complete phosphorylation of
Siz1 in nocodazole-arrested slx5∆ and WT cells.
PIAS1, an orthologue of Siz1 in mammalian cells, is phosphorylated by casein kinase 2 (Stehmeier and Muller, 2009). However, in
our experiments deletion of CKB1, the nonessential β regulatory
subunit of casein kinase 2 in budding yeast, did not appear to affect
the phosphorylation status of Siz1 (unpublished data). In summary,
our data reveal that the steady-state levels of both phosphorylated
and unphosphorylated Siz1 are increased in slx5∆ cells and that cell
cycle–dependent phosphorylation of Siz1 may somehow be involved in its regulation.

Slx5 is required to modulate the levels of Siz1 in the nucleus
We devised and tested a model to understand the functional interaction of Slx5 with Siz1 during mitosis. This model takes into account that nuclear export and septin ring localization of Siz1 requires
the karyopherin Msn5 and that in an msn5∆ mutant Siz1 accumulates in the nucleus, most likely in its phosphorylated form (Johnson
and Gupta, 2001; Makhnevych et al., 2007). We reasoned that nuclear retention of Siz1 could make it a substrate of the yeast Slx5/
Slx8 STUbL. Therefore we asked what would happen when nuclear
egress of the Siz1 protein is prevented in msn5∆ cells.
First, we observed GFP-tagged Siz1 in wild-type cells and compared it to slx5∆, msn5∆, and the msn5∆slx5∆ double mutant in
logarithmically growing and G2/M-arrested cells. Consistent with
previous results, Siz1-GFP is a nuclear protein but relocalizes to the
septin ring of G2/M-arrested wild-type cells (Figure 7A). We observed a similar localization in slx5∆ cells even though septin localization was reduced by ∼20%. However, in both the msn5∆ and the
msn5∆slx5∆ mutant, Siz1 was retained in the nucleus and could not
be detected at the septin ring. Of note, nuclear Siz1-GFP levels in
the msn5∆slx5∆ strain were considerably more pronounced than in
msn5∆ cell. The Siz1-GFP signal in the nucleus of msn5∆ cells averaged 60.1 ± 5.9% (n = 62 nuclei) compared with 70.6 ± 3.5% (n = 86
nuclei) in the msn5∆slx5∆ strain. These values represent a significant
increase of nuclear enrichment (Kruskal–Wallis test, 81.3; df = 1;
p < 0.001) in the absence of Slx5. This observation is consistent with
the accumulation of Siz1 in slx5∆ mutants and prompted us to further examine Siz1 levels in these mutants.
To confirm our observation, we performed a cycloheximide
chase of Siz1 in mitotically arrested WT and msn5∆ cells. Indeed, we
found that the half-life of Siz1 was dramatically reduced in the msn5∆
strain, with little endogenous Siz1 remaining after 60 min (Figure 7B).
In comparison, both phosphorylated and nonphosphorylated forms
of Siz1 were only slightly modulated in the WT strain. Finally, to
show that nuclear accumulated Siz1 is indeed an in vivo STUbL target once the cell enters mitosis, we performed a cycloheximide
chase of Siz1 in a msn5∆slx5∆ strain. Consistent with our prediction,
Siz1 was stabilized in the slx5∆msn5∆ double mutant but not the
msn5∆ mutant (Figure 7C). Furthermore, Siz1 sumoylation in the
slx5∆msn5∆ double mutant was maintained through the entire
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cycloheximide chase time course, whereas all forms of Siz1 were
rapidly degraded in the msn5∆ mutant.
Whether phosphorylation is solely required for Siz1’s nuclear export, precedes its sumoylation, or promotes other aspects of Siz1
function is not yet clear. Of importance, our data reveal for the first
time the functional interplay between SUMO E3 ligases and SUMOtargeted ubiquitin ligases. In summary, this STUbL-dependent regulation of nuclear localized Siz1 (see model in Figure 7D) may work in
cooperation with other pathways to prevent the accumulation of
specific nuclear SUMO conjugates that interfere with cell cycle progression or other vital processes.

DISCUSSION
We conducted an extensive structure–function analysis of the yeast
STUbL subunit Slx5. Our data suggest that Slx5 consists of distinct
and partially overlapping domains involved in its self-association
and its interactions with Slx8 and yeast SUMO. We also began the
functional dissection of a novel Slx5 interactor and STUbL target,
the SUMO E3 ligase Siz1.
In our structure–function analysis of Slx5 we identified a
new domain with an apparent role in nuclear localization of this
STUbL subunit. Specifically, we observed that a GFP-tagged fragment of Slx5, Slx5(207–310), is enriched in the nucleus (Figure 1).
Of importance, Slx5(207–310) contains an arginine-rich region
(207–RRIAERQRR–215), and similar features in other proteins have
been implicated in protein dimerization, nuclear transport, interaction with SH3 domain–containing proteins, and recognition of RNA
hairpins (Hibbard and Sandri-Goldin, 1995; Fagerlund et al., 2002;
Barylko et al., 2010). A conserved arginine-rich region has also
been described in the human STUbL orthologue RNF4, and it has
been suggested that this domain may be involved in detecting
ATM-phosphorylated proteins (Kuo et al., 2012). Using a second
construct that removes additional residues of the arginine cluster,
Slx5(∆189–260), we find reduced nuclear localization. Therefore,
based on our data, it is possible that this domain of the STUbL
subunit Slx5 is somehow involved in nuclear localization or retention. It is important to note that the same domain is also required
for the two-hybrid interaction of Slx5 with other Slx5 molecules.
However, the functional relevance of this interaction requires further investigation.
Unlike Slx5, Siz1 shows a cell cycle–dependent localization pattern. Nuclear-localized Siz1 becomes phosphorylated at G2/M, is
concomitantly exported, and then associates with septins at the bud
neck of dividing cells (Johnson and Gupta, 2001). Elegant work by
Makhnevych et al. (2007) showed that Msn5, a karyopherin that
transports phosphorylated cargoes, is involved in nuclear export of
Siz1 and that this export is required for septin sumoylation. Therefore Siz1 may contain a nuclear export signal that depends on phosphorylation to be recognized by Msn5 (for comparison see DeVit
and Johnston, 1999). Of interest, our work raises the possibility that
Siz1 phosphorylation may also be a prelude to STUbL-mediated
degradation, and we are exploring this possibility. The mammalian
Siz1 orthologue PIAS1, which is phosphorylated by casein kinase 2,
was recently found to contain a phosphoregulated SIM module.
This phosphoregulated SIM does not appear to affect the sumoylation or turnover of PIAS1 but is required to modulate the activity of
specific transcription factors (Stehmeier and Muller, 2009). A bona
fide SIM also exists at position 484–491 of Siz1, but we have not yet
determined whether it constitutes a phosphoregulated SIM module
(Uzunova et al., 2007).
One of the most intriguing implications of this work is that
STUbLs can regulate an important SUMO E3 ligase. In vitro and in
Molecular Biology of the Cell

vivo we detect robust ubiquitylation of a
truncated Siz1 construct, albeit only with
monoubiquitin and diubiquitin (Figure 5A).
Similar to other STUbL substrates, our in
vitro modification was also not dependent
on prior sumoylation of Siz1 (Xie et al., 2007,
2010). The same truncated Siz1 construct is
also ubiquitylated in vivo, and this modification depends on SLX5 (Figure 5B). In vivo,
sumoylation may be a prerequisite, because
our preliminary experiments suggest that a
RING mutant of this Siz1(Siz1(C377S H379A))
truncation fails to be ubiquitylated (N.P. and
O.K., unpublished observations). Ultimately
our data suggest that nuclear-localized
Siz1 interacts with Slx5, is degraded in a

FIGURE 7: Slx5 modulates the levels of Siz1 in the nucleus. (A) WT (YOK2738), slx5∆ (YOK2751),
msn5∆ (YOK2624), and msn5∆slx5∆ (YOK2735) strains expressing Siz1-GFP as the only copy of
this SUMO ligase were imaged during logarithmic growth (log; left) or after nocodazole-induced
G2/M arrest (Noc; right). The localization of Siz1-GFP at septins is indicated with yellow arrows,
and the localization of nuclei in msn5∆ and msn5∆slx5∆ strains is indicated with white
arrowheads. (B) Siz1 is rapidly degraded in an msn5∆ mutant. Isogenic WT (YOK 2397) and
msn5∆ (YOK 2514) strains expressing endogenous full-length Siz1-myc were grown overnight in
yeast extract/peptone/dextrose (YPD) medium. Cells in logarithmically grown cultures were
arrested with nocodazole. G2/M-arrested cells, 10 OD units, were pelleted, washed, and
Volume 25 January 1, 2014

resuspended in fresh YPD medium without
nocodazole containing 25 μg/ml
cycloheximide. Subsequently, protein
extracts of 2.5 OD units of cells were
prepared at the indicated time points (0, 10,
30, 60 min) before Western blotting to detect
Siz1-myc. Siz1 levels were normalized against
the Pgk1 loading control and graphed on the
right. (C) A deletion of SLX5 stabilizes Siz1 in
an msn5∆ mutant. Isogenic msn5∆ and
msn5∆slx5∆ strains expressing Siz1-myc from
LEU2/CEN plasmid pRS315 were grown
overnight in selective media. Cells in
logarithmically grown cultures were arrested
with nocodazole and benomyl. G2/M-arrested
cells, 22 OD units, were pelleted, washed,
and resuspended in fresh YPD medium
without nocodazole containing 25 μg/ml
cycloheximide. Subsequently, protein
extracts of 2 OD units of cells were prepared
at the indicated time points (0, 40, 60, 90,
120 min) before Western blotting to detect
Siz1-myc and Pgk1 proteins. The first two
lanes, msn5∆ (log) and msn5∆slx5∆ (log), are
overloaded to show SUMO adducts of Siz1 in
these strains. Siz1 levels were normalized
against the Pgk1 loading control and
graphed on the right. Siz1 protein levels,
normalized to the Pgk1 control, were
determined using a C-DiGit Western blot
scanner (Li-COR, Lincoln, NE) and Image
Studio software (Li-COR) and are shown
below each time point. (D) Model of a STUbLdependent nuclear degradation pathway of
sumoylated Siz1. At the onset of mitosis
nuclear Siz1 becomes autosumoylated (green
circles) and phosphorylated (p) via an
unknown kinase. Phosphorylated Siz1 may be
subject to Msn5-mediated nuclear export to
facilitate septin sumoylation in the cytosol.
Sumoylated Siz1 that remains in the nucleus
as the cell enters mitosis (in our experiments
this was accomplished through deletion of
MSN5) is subject to STUbL-mediated
ubiquitylation (circle labeled Ub) and
degradation. Other non–STUbL-dependent
pathways for the regulation of Siz1 activity
and levels may exist, and the exact structures
of the Siz1 conjugates are not known.
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STUbL-dependent manner, and accumulates sumoylated adducts
of Siz1 when SLX5 is absent (Figure 7C). These sumoylated adducts
of Siz1 may be retained in nuclei of slx5∆ cells, because we find a
∼20% reduction of Siz1 localization to the septin ring when cells are
arrested in nocodazole (C.E., J.W.W., and O.K., unpublished observations). However, another possibility is that autosumoylation of
Ubc9, which was recently shown to negatively affect septin sumoylation (Ho et al., 2011), is increased in slx5∆.
Are there nuclear versus cytosolic STUbL functions? Slx5 is a nuclear protein, and there is no evidence that it functionally interacts
with sumoylated proteins in the cytosol. Only the truncated Slx5
protein lacking a domain involved in nuclear localization and putative dimerization, Slx5(1–207), associates with the sumoylated septin ring in G2/M-arrested cells. Although not physiologically relevant, this helps to delineate a domain involved in nuclear localization
of Slx5 and shows which SIMs are involved in targeting the Slx5/Slx8
STUbL. Other cytosolic proteins are known to use a SUMO-binding
strategy to be recruited to the septin ring in a cell cycle–dependent
manner (Elmore et al., 2011). Is it possible that the various yeast
STUbLs are separated into distinct cellular compartments? For example, Slx5/Slx8 may function in the nucleus, whereas sumoylated
proteins in the cytosol are degraded by other STUbLs. Consistent
with this hypothesis, the STUbL protein Ris1 relocalizes to the cytosol upon replication stress, and other recent work suggests that Ris1
targets the microtubule-associated protein Pac1 in the cytosol
(Alonso et al., 2012; Tkach et al., 2012).
In conclusion, we predict that the degradation of Siz1 by Slx5/
Slx8 plays an important physiological role in reducing nuclear SUMO
E3 ligase activity as the cell enters mitosis. This novel process likely
works in parallel to the mitotic nuclear export pathway of Siz1 and
may help to prevent the accumulation of specific nuclear SUMO conjugates that interfere with cell cycle progression (see Introduction).
Considering that Slx5 and Siz1 are evolutionarily conserved proteins,
we predict that the STUbL-mediated regulation of SUMO-E3 ligases
extends to RNF4 and PIAS proteins in mammalian cells. Indeed, our
preliminary analysis indicates that RNF4 can interact with PIAS1 in
yeast two-hybrid and pull-down assays (Kerscher, Westerbeck, and
Semmes, unpublished observations). It will be interesting to determine whether RNF4 affects the turnover of PIAS1 in mammalian
cells. This would further support the emerging theme of interconnection and interdependence of SUMO and ubiquitin systems.

MATERIALS AND METHODS
Yeast strains, media, and plasmids
Yeast strains and plasmids used in this study are listed in Table 1.
Unless otherwise noted, yeast media preparation and manipulation
of yeast cells were performed as previously reported (Guthrie and
Fink, 2002). All strains were grown at 30°C unless otherwise noted.

Cell synchronization and drug treatments
Where indicated, yeast cells were synchronized in G2/M phase by
incubating logarithmically grown cells in 15 μg/ml nocodazole
(358240500; Acros Organics) for 3 h at 30°C. For cycloheximide
chase experiments, 25 μg/ml cycloheximide (C7698; Sigma-Aldrich,
St. Louis, MO) was added to G2/M-arrested cells. We harvested
2.5 OD units of cells at the indicated time points. Cells were arrested
in S phase by addition of 0.1 M hydroxyurea (H8627; Sigma-Aldrich)
and incubation at 30°C for 3 h.

Cloning and epitope tagging of yeast genes
Slx5 and Slx5 domains under control of its endogenous promoter
were PCR amplified from yeast genomic DNA and placed in-frame
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with a carboxy-terminal GFP tag in CEN/LEU2 plasmid pAA3 (Sesaki
and Jensen, 1999; Cook et al., 2009). Nuclear versus cytosolic localization of GFP-tagged constructs was confirmed using 4′,6-diamidino-2-phenylindole. For galactose-inducible expression of Siz1(∆440)
in yeast, the open reading frame (ORF) was PCR amplified and
cloned into the pCR8/GW/TOPO entry vector (Life Technologies,
Grand Island, NY) and then recombined into pAG425GAL-ccdBHA/LEU2 (plasmid 14249; Addgene, Cambridge MA), forming GalSiz1∆440-HA/LEU2/2 μ (plasmid BOK795). For in vivo pull-down assays a plasmid expressing GST-tagged Slx5 (YSC4515-202484078)
was purchased from the Thermo Scientific Life Science Research
Yeast (Thermo Scientific, Pittsburgh PA) GST-tagged ORF Collection
(formerly Open Biosystems). For two-hybrid constructs, ORFs or
truncations of the indicated genes were PCR amplified, homologously recombined into gapped pOAD and pOBD2 vectors, and
transformed into AH109 (YOK1220) strains as specified (Yeast Resource Center, University of Washington, Seattle, WA). Two-hybrid
interactions were scored on dropout media lacking adenine as specified in the Clontech Yeast Protocols Handbook (protocol PT3024-1;
Clontech Laboratories). Chromosomal tagging and gene deletions
in yeast were carried out by PCR-based homologous recombination
(Longtine et al., 1998). Strain YOK821 (slx5Δ) was used to epitope
tag SIZ1 with a 13-myc epitope tag. Briefly, primers OOK663 and
OOK662 were used to amplify the 13xmyc-TADH1-His3MX6 cassette with 40 base pairs of SIZ1 sequence homology from the plasmid pFA6a-13myc-His3MX6 (Longtine et al., 1998). PCR amplification was carried out using the Phusion High-Fidelity PCR kit (E0553S;
New England BioLabs, Ipswich, MA) with dimethylsulfoxide and
high-GC buffer as recommended by the manufacturer. For transformation, 6.5 μg of purified SIZ1-13myc-His3MX6 PCR product was
combined with 4 OD units of competent slx5∆ (YOK821) cells, incubated for 30 min at 30°C, heat shocked at 42°C for 30 min, and
plated on SD –His dropout. Resulting colonies were screened by
Western blotting using an anti-myc antibody. Subsequently, the
SIZ1-myc slx5∆ strain (YOK2264) was backcrossed to YOK819 to obtain SIZ1-myc SLX5(WT) progeny (YOK2286). An amplicon of SIZ113myc was also cloned into a Gateway-compatible pRS315 plasmid.
The msn5-null mutant was constructed by introducing a hygromycin
deletion cassette with 78–base pair flanking sequence homology to
msn5 gene upstream and downstream region. The primer pairs for
amplification of a MSN5-specific hygromycin deletion cassette in
plasmid pAG32 were OOK763 and OOK764 and for re-PCR were
OOK767 (MSN5[−78 to −19] and OOK768 (MSN5[+3692–3751]).
All primer sequences are available upon request.

Recombinant proteins
For the in vitro ubiquitylation and pull-down assays recombinant
MBP-Slx5, MBP-Slx8, and His6-Ubc4 were prepared as previously
reported (Xie et al., 2007; Fryrear et al., 2012). Recombinant
Siz1(∆440) was expressed from plasmid pT-77-SIZ1∆440-His obtained from Addgene (plasmid 16087; Takahashi and Kikuchi, 2005).
CUP1-driven UbiG76A and mycUbi-G76A plasmids expressing deubiquitylation-resistant mutants of ubiquitin were a gift from Tommer
Ravid (The Hebrew University of Jerusalem).

Pull-down assays, affinity purification, and protein extracts
MBP-Slx5, MBP-Slx8, and T7-Siz1∆440 were overexpressed in
BL21(DE3) or *R cells by isopropyl-β-d-thiogalactoside induction as
previously described (Xie et al., 2007). We combined 50 OD units of
cells overexpressing either MBP-Slx5 or MBP-Slx8 with 50 OD units
of cells overexpressing T7-Siz1∆440. We also collected 50 OD units
of cells overexpressing T7-Siz1∆440. Whole-cell protein extracts
Molecular Biology of the Cell

Name

Pertinent genotype or background

Plasmid or construction

Reference

MHY500 (YOK819)

Mata his3-Δ200 leu2-3, 112 ura3-52 lys2801trp1-1gal2

MHY501 (YOK820)

Matα his3-Δ200 leu2-3, 112 ura3-52 lys2801trp1-1 gal2

BY4741 (YOK1322)

MATa leu2Δ0 met15Δ0 ura3Δ0

Brachmann et al.
(1998)

JD52 (YOK2062)

MATa ura3-52 his3-Δ200 leu2-3112 trp1-Δ63
lys2-801

Dohmen et al.
(1995)

AH109 (YOK1220)

MATa, trp1-901, leu2-3, 112, ura3-52, his3200, gal4Δ, gal80Δ, LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2,
URA3::MEL1UASMEL1TATA-lacZ, MEL1

Cat. No. 630444;
Clontech,
Mountain View,
CA

YOK1369

BY4741 (YOK1322)

SLX5(1-50)-GFP/LEU2 (BOK514)

This study

YOK1370

BY4741 (YOK1322)

SLX5(1-104)-GFP/LEU2 (BOK515)

This study

Li and Hochstrasser (2003)

YOK1372

BY4741 (YOK1322)

SLX5(1-310)-GFP/LEU2 (BOK517)

This study

YOK1373

BY4741 (YOK1322)

SLX5(1-414)-GFP/LEU2 (BOK518)

This study

YOK1374

BY4741 (YOK1322)

SLX5(1-517)-GFP/LEU2 (BOK519)

This study

YOK1375

BY4741 (YOK1322)

SLX5(1-207)-GFP/LEU2 (BOK507)

This study

YOK1830

MHY500

SLX5(208-310)-GFP/LEU2 (BOK637)

This study

YOK1408

AH109

SLX5(1-104)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1411

AH109

SLX5(1-207)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1414

AH109

SLX5(1-310)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1417

AH109

SLX5(1-414)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1420

AH109

SLX5(1-517)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1423

AH109

SLX5(51-620)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1425

AH109

SLX5(105-620)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1428

AH109

SLX5(208-620)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1431

AH109

SLX5(311-620)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1434

AH109

SLX5(415-620)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1437

AH109

SLX5(1-104)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1440

AH109

SLX5(1-207)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1443

AH109

SLX5(1-310)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1446

AH109

SLX5(1-414)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1449

AH109

SLX5(1-517)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

TABLE 1: Strains and plasmids used in this study.
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Pertinent genotype or background
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YOK1452

AH109

SLX5(51-620)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1455

AH109

SLX5(105-620)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1458

AH109

SLX5(208-620)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1461

AH109

SLX5(311-620)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1464

AH109

SLX5(415-620)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1467

AH109

SLX5-BD/TRP (BOK440); SlX5-AD/LEU2
(BOK289)

This study

YOK1470

AH109

SLX5-BD/TRP (BOK440); SLX8-AD/LEU2
(BOK311)

This study

YOK1518

AH109

SLX5-BD/TRP (BOK440); SMT3-AD/LEU2
(BOK571)

This study

YOK1547

AH109

SLX5(1-50)-BD/TRP SMT3-AD/LEU2
(BOK571)

This study

YOK1550

AH109

SLX5(1-104)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1553

AH109

SLX5(1-207)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1556

AH109

SLX5(1-310)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1559

AH109

SLX5(1-414)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1562

AH109

SLX5(1-517)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1565

AH109

SLX5(51-620)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1568

AH109

SLX5(311-620)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1571

AH109

SLX5(208-620)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1574

AH109

SLX5(311-620)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1577

AH109

SLX5(415-620)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1580

AH109

SLX5(518-620)-BD/TRP; SMT3-AD/LEU2
(BOK571)

This study

YOK1583

AH109

SLX5(518-620)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1586

AH109

SLX5(518-620)-BD/TRP; SLX5-AD/LEU2
(BOK289)

This study

YOK1589

AH109

SLX5(1-50)-BD/TRP SLX8-AD/LEU2 (BOK311) This study

YOK1592

AH109

SLX5(1-50)-BD/TRP SLX5-AD/LEU2 (BOK289) This study

YOK1595

AH109

SLX5-BD/TRP (BOK440); SIZ1-AD/LEU2
(BOK582)

This study

YOK1621

AH109

SLX5(1-50)-BD/TRP SIZ1-AD/LEU2 (BOK582)

This study

TABLE 1: Strains and plasmids used in this study.
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Pertinent genotype or background

Plasmid or construction

Reference

YOK1625

AH109

SLX5(1-104)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1627

AH109

SLX5(1-207)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1630

AH109

SLX5(1-310)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1633

AH109

SLX5(1-414)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1636

AH109

SLX5(1-517)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1639

AH109

SLX5(51-620)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1642

AH109

SLX5(311-620)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1645

AH109

SLX5(208-620)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1648

AH109

SLX5(311-620)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1651

AH109

SLX5(415-620)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1654

AH109

SLX5(518-620)-BD/TRP; SIZ1-AD/LEU2
(BOK582)

This study

YOK1796

AH109

SLX5(SIMAB)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1797

AH109

SLX5(SIMAB)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1798

AH109

SLX5(SIMAB)-BD/TRP; SLX8-AD/LEU2
(BOK311)

This study

YOK1799

AH109

SLX5(SIMAB)-BD/TRP (BOK627); SMT3-AD/
LEU2 (BOK571)

This study

YOK1800

AH109

SLX5(SIMAB)-BD/TRP(BOK627); SMT3-AD/
LEU2 (BOK571)

This study

YOK1801

AH109

SLX5(SIMAB)-BD/TRP(BOK627); SMT3-AD/
LEU2 (BOK571)

This study

YOK2396

slx5::KanMX4 SIZ1-13xmyc/HIS5 in JD52

YOK 2373 transformed with SIZ1-13xmyc/
HIS5

This study

YOK2397

SIZ1-13xmyc/HIS5 in JD52

YOK 2062 transformed with SIZ1-13xmyc/
HIS5

This study

YOK2514

msn5::HYG SIZ1-13xmyc/HIS5 in JD52

YOK 2397 transformed with msn5::HYG

This study

YOK2513

msn5::HYG, slx5::KanMX4 SIZ1-13xmyc/HIS5

YOK 2396 transformed with msn5::HYG

This study

YOK3712
(MHY821)

slx5::KANMX4

YOK2264

slx5Δ SIZ1-13xmyc/HIS5

MHY821 transformed with SIZ1-13xmyc/HIS5 This study

YOK2286

SIZ1-13xmyc/HIS5

MHY501 transformed with SIZ1-13xmyc/HIS5 This study

YOK2373

slx5::KANMX4 in JD52

YOK2062 with integrated slx5::KANMX4
cassette

This study

YOK2505

msn5::HYG in JD52

YOK2062 with integrated msn5::HYG
cassette

This study

YOK2681

slx5::KANMX4 msn5::HYG in JD52

YOK2062 with integrated slx5::KANMX4 and
msn5::HYG cassettes

This study

TABLE 1: Strains and plasmids used in this study.
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Pertinent genotype or background
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YOK2738

SIZ1-GFP/HIS5 in JD52

YOK 2062 transformed with SIZ1-GFP/HIS5

This study

YOK2751

slx5::KANMX4 SIZ1-GFP/HIS5 in JD52

YOK 2373 transformed with SIZ1-GFP/HIS5

This study

YOK2624

msn5::HYG SIZ1-GFP/HIS5 in JD52

YOK2505 transformed with SIZ1-GFP/HIS5

This study

YOK2735

slx5::KANMX4 msn5::HYG SIZ1-GFP/HIS5 in
JD52

YOK2681 transformed with SIZ1-GFP/HIS5

This study

YOK2757

slx5::KANMX4 in JD52

YOK2373 transformed with SIZ1-13xmyc/
LEU2 on pRS315 (BOK982)

This study

YOK2759

msn5::HYG in JD52

YOK2505 transformed with SIZ1-13xmyc/
LEU2 on pRS315 (BOK982)

This study

YOK2761

slx5::KanMX4 msn5::HYG in JD52

YOK2681 transformed with SIZ1-13xmyc/
LEU2 on pRS315 (BOK982)

This study

YOK2501

MHY3765: MATalpha ura3-52, lys2-801,
trp1-Δ63, his3-Δ200, leu2-Δ1, ubc4::HIS3,
ubc6::TRP1, alpha2::KanMX

YOK2507

YOK2501 + pGAL1/10-GST-Slx5

BOK629 (GAL1/10-GST-Slx5) (Open Biosystems Yeast GST Collection) transformed into
YOK2501

This study

YOK2508

YOK2501 + pGAL1-ccdB-Siz1∆440-HA

BOK795 transformed into 2501

This study

YOK2509

YOK250 + pGAL1/10-GST-Slx5; pGAL1-ccdB- BOK629 and BOK795 transformed into
Siz1∆440-HA
YOK2501

YOK2379

pYES2.1-GAL- Siz1Δ440-V5/His6-TOPO;
CUP1-UbiG76A-myc in JD52

BOK794 and BOK309 transformed into
YOK2062

YOK2381

slx5::KAN YOK2373 + pYES2.1-GALSiz1Δ440-V5/His6-TOPO; CUP1-UbiG76Amyc

BOK794 and BOK309 transformed into
YOK2373

Xie et al. (2010)

This study

TABLE 1: Strains and plasmids used in this study. Continued

were then isolated and passed over a column containing amylose
resin (E8021L; New England BioLabs). Proteins bound to the amylose resin were eluted with 1× LDS Sample Buffer (NP0007; Life Technologies) and analyzed by Western blotting as described later. To
determine whether Slx5 and Siz1 interacted in vivo, GAL1/10-GSTSlx5 (BOK 629, Open Biosystems Yeast GST Collection YSC4515202484078), pAG425-GAL1-ccdB-Siz1(∆440)-HA (BOK795), or both
GST-Slx5 and Siz1(∆440)-HA were transformed into ubc4∆ ubc6∆
cells (YOK2501, Xie et al., 2010) to form YOK2507, YOK2508, and
YOK2509, respectively. Copurification experiments were done as
described in Szymanski and Kerscher (2013). Transformants were
grown in 33 ml of the appropriate selective media containing 2%
sucrose until mid–log phase (OD600 = 0.8–1.0). At this point, 17 ml
of 3× yeast extract peptone (YEP) with 6% galactose was added to
each culture, for a final concentration of 1× YEP and 2% galactose in
a final volume of 50 ml. Cells were allowed to grow for another 6 h
before harvesting. We washed 200 OD units worth of yeast cells
with 1× ice-cold phosphate-buffered saline plus 1× protease inhibitor cocktail (1860932; Thermo Scientific), snap froze them in liquid
nitrogen, and stored them at −80°C until further use. To extract proteins, frozen cell pellets were lysed in 500 μl of HNT buffer (50 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES] at pH
7.3, 200 mM NaCl, 1% Triton X-100) containing 25 mM N-ethylmaleimide (NEM), 1 mM sodium orthovanadate, and 1× protease inhibitor cocktail (G6521; Promega, Madison, WI), and 200 μl of acidwashed beads (425–600 μm; Sigma-Aldrich) were placed in an Omni
Bead Ruptor 24 (six 20-s pulses with 1 min on slushy ice between
each pulse). The lysate was clarified by centrifugation at 15,000 rpm
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for 15 min at 4°C. We added 100 μl of clarified lysate (corresponding to 20 OD units) to 100 μl of immobilized glutathione agarose
(15160; Thermo Scientific) that had been equilibrated with HNT buffer and increased the final volume to 1 ml with HNT buffer plus 25
mM NEM, 1 mM sodium orthovanadate, and 1× protease inhibitor
cocktail (1860932; Thermo Scientific). Extracts were rotated top
over bottom with the glutathione agarose for 2.5 h at 4°C. Agarose
beads were then washed five times with HNT buffer. We saved 100
μl of the flowthrough and precipitated proteins by addition of 1 ml
of 20% trichloroacetic acid (TCA). Glutathione agarose–bound proteins were eluted by top-over-bottom rotation with 100 μl of elution
buffer (50 mM HEPES at pH 7.3, 200 mM NaCl, 10 mM reduced
glutathione [120000010; Acros Organics]) for 5 min. Three elutions
were performed and pooled before analysis of proteins by SDS–
PAGE and Western blotting. The Ubi(G76A) construct was induced as
previously reported (Ravid and Hochstrasser, 2007), and extracts
were prepared as listed except that 20 μM MG132 was added to the
cultures and anti–V5-agarose was used for immunoprecipitations
(A7345; Sigma-Aldrich).

Preparation of whole-cell yeast extracts, gel electrophoresis,
and Western blotting
Whole-cell yeast extracts were prepared by TCA glass bead lysis.
Whole-cell protein extracts corresponding to ∼0.2 OD unit were separated on a precast NuPAGE Novex 4–12% Bis-Tris gels (NP0321; Life
Technologies) or home-made 8% Tris-glycine gels. After separation,
proteins were transferred to polyvinylidene difluoride membrane
(IPVH00010; Millipore, Billerica, MA) for 25 min at 19 V. Blots were
Molecular Biology of the Cell

blocked in TBS (150 mM NaCl, 50 mM Tris-HCl at pH 7.4) containing 4% milk for 1 h and then incubated in 4% milk containing
primary antibody overnight, followed by incubation with secondary
antibodies for 1–3 h at ambient temperature. After antibody incubations, blots were extensively washed in TBS plus 0.1% Tween 20
(TBST). Anti-GST antibody (1:5000 dilution, ab6613; Abcam), antihemagglutinin (HA) antibody (1:10,000, ab9110; Abcam), anti-T7
(1:10,000 dilution, 69522-3; Novagen [EMD Millipore], Billerica,
MA), anti-myc (1:5000, MMS-150R; Covance, Princeton, NJ), antiPgk (1:10,000, A6457; Life Technologies), anti-GST (1:5000, ab6613,
Abcam), anti-FLAG (1:10,000, F3165; Sigma-Aldrich), anti-mouse
horseradish peroxidase (HRP; 1:15,000, ab9740; Abcam), and antirabbit HRP (1:20,000, ab6721; Abcam). Proteins were visualized on
film using enhanced chemiluminescence substrate (Immobilon
Western ECL substrate WBKL S0 100; Millipore).

In vitro ubiquitylation reactions
Sizing and quantitation of enzymes and substrates used in our in
vitro ubiquitylation assays were performed with a Protein 230 kit on
the Agilent 2100 Bioanalyzer according to the manufacturer’s
instructions. The 10× ubiquitylation buffer, E1 enzyme (Uba1),
ATP, and 20× ubiquitin were provided in a commercial ubiquitylation kit (Enzo). Ubiquitylation buffer, inorganic pyrophosphatase
(IPP; 100 U/ml), dithiothreitol (DTT; 50 μM), E1 (Uba1), E2 (Ubc4),
and E3 enzyme (Slx5-Slx8) were combined with purified substrate
protein (T7-Siz1∆440) and ubiquitin as previously reported (Xie
et al., 2007). Reactions totaled 27 μl and were incubated in a 30°C
heat block for 3 h. Molar ratios of components in the STUbL ubiquitylation reactions were as follows (μM): E1(Uba1), 0.1; E2(Ubc4),
0.4; E3 (Slx5/Slx8), 0.12 each; and substrate (Siz1∆440), 0.03. Reactions were stopped by adding an equal volume of SUTEB sample
buffer (0.01% bromophenol blue, 10 mM EDTA, 1% SDS, 50 mM
Tris at pH 6.8, 8 M urea) containing DTT (5 μl of 1 M DTT/1 ml
SUTEB sample buffer). Protein products were boiled in a 65°C heat
block for 10 min, frozen in liquid nitrogen, stored at −80°C, and
analyzed by Western blot as described.

Fluorescence microscopy
Images of live cells were collected using a Zeiss Axioskop fitted with
a Retiga SRV camera (Q-imaging), i-Vision software (BioVision Technologies), and a Uniblitz shutter assembly (Rochester, NY). Pertinent
filter sets for the applications include CZ909 (GFP), XF114-2 (CFP),
and XF104-2 (YFP; Chroma Technology Group, Bellows Falls, VT).
Where applicable, images were normalized using i-Vision software
and pseudocolored and adjusted using Photoshop software (Adobe
Systems, San Jose, CA).
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